Optimizing a Diagnostic Model of Periodontitis by Using Targeted Proteomics

被引:4
|
作者
Reckelkamm, Stefan Lars [2 ]
Kaminska, Inga [1 ]
Baumeister, Sebastian-Edgar [2 ]
Holtfreter, Birte [3 ]
Alayash, Zoheir [2 ]
Rodakowska, Ewa [4 ]
Baginska, Joanna [5 ]
Kaminski, Karol Adam [6 ]
Nolde, Michael [2 ]
机构
[1] Med Univ Bialystok, Dept Integrated Dent, PL-15276 Bialystok, Poland
[2] Univ Munster, Inst Hlth Serv Res Dent, D-48149 Munster, Germany
[3] Univ Med Greifswald, Dept Restorat Dent Periodontol Endodontol & Preve, D-17475 Greifswald, Germany
[4] Univ Bergen, Dept Clin Dent, Cariol Sect, N-5020 Bergen, Norway
[5] Med Univ Bialystok, Dept Dent Propaedeut, PL-15276 Bialystok, Poland
[6] Med Univ Bialystok, Dept Populat Med & Lifestyle Dis Prevent, PL-15269 Bialystok, Poland
关键词
proteomics; prediction model; periodontitis; serum biomarkers; DISEASES; CD46; EXPRESSION; LIFE;
D O I
10.1021/acs.jproteome.3c00230
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Periodontitis (PD), a widespreadchronic infectious disease,compromisesoral health and is associated with various systemic conditions andhematological alterations. Yet, to date, it is not clear whether serumprotein profiling improves the assessment of PD. We collected generalhealth data, performed dental examinations, and generated serum proteinprofiles using novel Proximity Extension Assay technology for 654participants of the Bialystok PLUS study. To evaluate the incrementalbenefit of proteomics, we constructed two logistic regression modelsassessing the risk of having PD according to the CDC/AAP definition;the first one contained established PD predictors, and in addition,the second one was enhanced by extensive protein information. We thencompared both models in terms of overall fit, discrimination, andcalibration. For internal model validation, we performed bootstrapresampling (n = 2000). We identified 14 proteins,which improved the global fit and discrimination of a model of establishedPD risk factors, while maintaining reasonable calibration (area underthe curve 0.82 vs 0.86; P < 0.001). Our resultssuggest that proteomic technologies offer an interesting advancementin the goal of finding easy-to-use and scalable diagnostic applicationsfor PD that do not require direct examination of the periodontium.
引用
收藏
页码:2509 / 2515
页数:7
相关论文
共 50 条
  • [41] Towards the targeted management of aggressive periodontitis
    Yussif, Nermin M.
    Hosny, Manal M.
    MEDICAL HYPOTHESES, 2017, 103 : 124 - 127
  • [42] Complement-Targeted Therapeutics in Periodontitis
    Hajishengallis, George
    Lambris, John D.
    COMPLEMENT THERAPEUTICS, 2013, 735 : 197 - 206
  • [43] Proteomics approach for biomarkers and diagnosis of periodontitis: systematic review
    Rizal, Muhammad Ihsan
    Soeroso, Yuniarti
    Sulijaya, Benso
    Assiddiq, Bobby F.
    Bachtiar, Endang W.
    Bachtiar, Boy M.
    HELIYON, 2020, 6 (06)
  • [44] Proteomics for the discovery of biomarkers and diagnosis of periodontitis: a critical review
    Guzman, Yannis A.
    Sakellari, Dimitra
    Arsenakis, Minas
    Floudas, Christodoulos A.
    EXPERT REVIEW OF PROTEOMICS, 2014, 11 (01) : 31 - 41
  • [45] Construction of artificial neural network diagnostic model and analysis of immune infiltration for periodontitis
    Xiang, Junwei
    Huang, Wenkai
    He, Yaodong
    Li, Yunshan
    Wang, Yuanyin
    Chen, Ran
    FRONTIERS IN GENETICS, 2022, 13
  • [46] OPTIMIZING DRUG TREATMENT OF PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS USING A COMBINATION OF FLUOROQUINOLONES AND ORNIDAZOLE
    Malik, N. E.
    WORLD OF MEDICINE AND BIOLOGY, 2012, 32 (01): : 85 - 88
  • [47] Predictive diagnostic of chronic allograft dysfunction using urinary proteomics analysis
    Tetaz, Rachel
    Trocme, Candice
    Roustit, Mathieu
    Pinel, Nicole
    Bayle, Francois
    Toussaint, Bertrand
    Zaoui, Philippe
    ANNALS OF TRANSPLANTATION, 2012, 17 (03) : 52 - 60
  • [48] Identification of diagnostic and prognostic biomarkers of PD using a multiplex proteomics approach
    Maple-Grodem, Jodi
    Ushakova, Anastasia
    Pedersen, Kenn Freddy
    Tysnes, Ole-Bjorn
    Alves, Guido
    Lange, Johannes
    NEUROBIOLOGY OF DISEASE, 2023, 186
  • [49] Proteomics: A new diagnostic frontier
    Hortin, GL
    Jortani, SA
    Ritchie, JC
    Valdes, R
    Chan, DW
    CLINICAL CHEMISTRY, 2006, 52 (07) : 1218 - 1222
  • [50] Diagnostic Proteomics: Will this impact the clinic?
    Sauer, Sascha
    PROTEOMICS CLINICAL APPLICATIONS, 2013, 7 (11-12) : 725 - 726